Do predictors exist for the therapeutic effect of 5-HT3 receptor antagonists in fibromyalgia?

Scandinavian Journal of Rheumatology, Supplement

Volumn 29, Issue 113, 2000, Pages 63-65

  Stratz, T ^a   Muller W ^a  

^a Rheumaklinik ^*  (Germany)

Author keywords

3 HT3 receptor antagonists; Fibromyalgia; Treatment; Tropisetron

Indexed keywords

ADRENALIN; CALCITONIN; CALCITONIN GENE RELATED PEPTIDE; CHOLECYSTOKININ; DOPAMINE; NORADRENALIN; SEROTONIN 3 ANTAGONIST; TROPISETRON; SEROTONIN 3 RECEPTOR; SEROTONIN ANTAGONIST; SEROTONIN RECEPTOR;

CATECHOLAMINE BLOOD LEVEL; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; DRUG RESPONSE; FIBROMYALGIA; HUMAN; IMMUNOCHEMISTRY; MAJOR CLINICAL STUDY; PAIN ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; ARTICLE; DOUBLE BLIND PROCEDURE; PAIN; PATHOPHYSIOLOGY; PHYSIOLOGY; PREDICTION AND FORECASTING; PSYCHOMETRY; RANDOMIZED CONTROLLED TRIAL;

DEPRESSION; DOUBLE-BLIND METHOD; FIBROMYALGIA; HUMANS; PAIN; PAIN MEASUREMENT; PREDICTIVE VALUE OF TESTS; PSYCHOMETRICS; RECEPTORS, SEROTONIN; RECEPTORS, SEROTONIN, 5-HT3; SEROTONIN ANTAGONISTS;

EID: 0034536867     PISSN: 03013847     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (6)

1. Färber L, Stratz Th, Müller W. New Aspects for the Medical Treatment of Results of a Double-Blind, Randomized, Placebo-Controlled Multi-Centre Trial Evaluating the Efficacy and Tolerability of the 5-HT3-Antagonist Tropisetron in Primary Fibromyalgia. Z Rheumatol 1998;57 Suppl 1:30-2.
2. Müller W, Lautenschläger J. Die generalisierte Tendomyo-pathie (GTM) Teil I: Klinik Verlauf und Differentialdiagnose. Z Rheumatol 1990;49:11-21.
3. Ploghaus A, Tracey I, Gati JG, Clare S, Menon RS, Matthews PM, Rawlins JN, Dissociating pain form its anticipation in the human brain Amer. Assoc. Advanc. Science 1999;284:1979 -81.
4. Stratz Th, Schochat T, Hrycaj P, Lacki J, Mennet P, Färber L, Schweiger Ch, Müller W. Die Therapie der generalisierten Tendomyopathie (Fibromyalgie) durch Blockierung der 5-HT3-Rezeptoren. Z Rheumatol 1994;53:335-8.
5. Stratz Th, Schochat T, Färber L, Schweiger Ch, Müller W. Are there subgroups in fibromyalgia? J Musculoskel Pain 1995;3 Suppl 1:15.
6. Varga B, Färber L, Kohnen R, Stratz Th, Wild J, Müller W 4-wöchige Therapie mit dem 5-HT3-Rezeptor-Antagonisten Tropisetron bei der Fibromyalgie - eine offene kontrollierte Pilotstudie. Act Rheumatol 2000;25:43-50.